To the best of our knowledge, the frequency of positivity of anti-PF4 antibodies following COVID-19 vaccination (ChAdOx1 nCov-19 and BNT162b2) ranges from 1.2% to 6.8%, without VITT [33,34]. This evidence concerns the gene PF4 and COVID-19.